Leukocytosis and Thrombosis At Diagnosis Are Associated with Poor Survival in Polycythemia Vera: A Population-Based Study on 327 Patients

François Girodon(Inserm), Marc Maynadié(Université de Bourgogne), Morgane Mounier(Université de Bourgogne), Khadija Abdulkarim(Sahlgrenska University Hospital), Björn Andréasson(NU Hospital Group), Valérie Jooste(Inserm), Peter Johansson(Linköping University), Gilles Bonicelli(CHU Dijon Bourgogne)
Blood
November 18, 2011
10.1182/blood.v118.21.2819.2819
Cited by 1

Related Papers

Myeloproliferative Neoplasm (MPN) Symptom Assessment Form Total Symptom Score: Prospective International Assessment of an Abbreviated Symptom Burden Scoring System Among Patients With MPNs
|Journal of Clinical Oncology|2012|461
The Myeloproliferative Neoplasm Symptom Assessment Form (MPN-SAF): International Prospective Validation and Reliability Trial in 402 patients
|Blood|2011|340
Etiologic Heterogeneity Among Non-Hodgkin Lymphoma Subtypes: The InterLymph Non-Hodgkin Lymphoma Subtypes Project
|JNCI Monographs|2014|334
A prognostic model to predict survival in 867 World Health Organization–defined essential thrombocythemia at diagnosis: a study by the International Working Group on Myelofibrosis Research and Treatment
|Blood|2012|270
Treatment-Related Risk Factors for Transformation to Acute Myeloid Leukemia and Myelodysplastic Syndromes in Myeloproliferative Neoplasms
|Journal of Clinical Oncology|2011|244